Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 379-384 , March 2010

Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men

  • Helena Petersson

      Affiliations

    • Department of Public Health and Caring Sciences/Clinical Nutrition and Metabolism, Uppsala University, Uppsala Science Park, 75185 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 18 6117980; fax: +46 18 6117976.
    • ,
  • Johan Ärnlöv

      Affiliations

    • Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala Science Park, 75185 Uppsala, Sweden
    • Department of Health and Social Sciences, Högskolan Dalarna, 79188 Falun, Sweden
    • ,
  • Björn Zethelius

      Affiliations

    • Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala Science Park, 75185 Uppsala, Sweden
    • ,
  • Ulf Risérus

      Affiliations

    • Department of Public Health and Caring Sciences/Clinical Nutrition and Metabolism, Uppsala University, Uppsala Science Park, 75185 Uppsala, Sweden

Received 13 August 2009 ,Revised 23 October 2009 ,Accepted 24 November 2009.

References 

  1. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2008;28:27–38
  2. Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab. 2005;90:2804–2809
  3. Tiikkainen M, Bergholm R, Vehkavaara S, Rissanen A, Hakkinen AM, Tamminen M, et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes. 2003;52:701–707
  4. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology. 2003;38:1529–1539
  5. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008;47:348–380
  6. de Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin. Nutr. 2002;21:219–223
  7. Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 2004;24:345–376
  8. Chu K, Miyazaki M, Man WC, Ntambi JM. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol. Cell. Biol. 2006;26:6786–6798
  9. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, et al. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes. 2009;58:203–208
  10. Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups. J. Med. Sci. Suppl. 1975;19:1–61
  11. Skarfors ET, Selinus KI, Lithell HO. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ. 1991;303:755–760
  12. Boberg M, Croon LB, Gustafsson IB, Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin. Sci. (Lond.). 1985;68:581–587
  13. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979;237:E214–223
  14. Byberg L, Zethelius B, McKeigue PM, Lithell HO. Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia. 2001;44:2134–2139
  15. Riserus U, Ingelsson E. Alcohol intake, insulin resistance, and abdominal obesity in elderly men. Obesity (Silver Spring). 2007;15:1766–1773
  16. Dobrzyn A, Ntambi JM. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes. Rev. 2005;6:169–174
  17. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond.). 2004;106:635–643
  18. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J. Hepatol. 2008;48:300–307
  19. Westerterp KR, Smeets A, Lejeune MP, Wouters-Adriaens MP, Westerterp-Plantenga MS. Dietary fat oxidation as a function of body fat. Am. J. Clin. Nutr. 2008;87:132–135
  20. Stefan N, Peter A, Cegan A, Staiger H, Machann J, Schick F, et al. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia. 2008;51:648–656
  21. Warensjo E, Riserus U, Gustafsson IB, Mohsen R, Cederholm T, Vessby B. Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr. Metab. Cardiovasc. Dis. 2008;18:683–690
  22. Chong MF, Hodson L, Bickerton AS, Roberts R, Neville M, Karpe F, et al. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am. J. Clin. Nutr. 2008;87:817–823
  23. Petersson H, Basu S, Cederholm T, Riserus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men. Br. J. Nutr. 2008;99:1186–1189
  24. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 2003;78:91–98
  25. Riserus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 2009;48:44–51
  26. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol. Rev. 2006;86:465–514
  27. Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J. Lipid Res. 2002;43:1899–1907
  28. Liu G, Lynch JK, Freeman J, Liu B, Xin Z, Zhao H, et al. Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors. J. Med. Chem. 2007;50:3086–3100

☆ This study was presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) 2008.

PII: S0168-8227(09)00490-2

doi: 10.1016/j.diabres.2009.11.019

Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 379-384 , March 2010

Article Tools